1
/
의
1
Elabscience
SKU(재고 관리 코드):PKSV030308
Recombinant SARS-CoV-2 S Protein RBD (C-6His) V2(Active)
Recombinant SARS-CoV-2 S Protein RBD (C-6His) V2(Active)
Introducing the Recombinant SARS-CoV-2 S Protein RBD (C-6His) V2(Active), a cutting-edge product designed to aid in the study and understanding of the SARS-CoV-2 virus. This product is a recombinant protein that contains the SARS-CoV-2 Spike (S) protein receptor-binding domain (RBD) with a C-terminal 6-His tag. The V2 variant of this protein is active and has been optimized for use in various applications, including ELISA, SPR, and other binding assays.
The Recombinant SARS-CoV-2 S Protein RBD (C-6His) V2(Active) is produced using advanced recombinant DNA technology, ensuring high purity and quality. This product is ideal for researchers and scientists who are studying the SARS-CoV-2 virus and its interactions with human cells. It can be used to investigate the mechanisms of viral entry and to develop potential treatments and vaccines.
This product is supplied in a lyophilized form, making it easy to store and transport. It is also available in various quantities to suit the needs of different research projects. The Recombinant SARS-CoV-2 S Protein RBD (C-6His) V2(Active) is a valuable tool for researchers and scientists who are working towards a better understanding of the SARS-CoV-2 virus and its impact on human health.
The Recombinant SARS-CoV-2 S Protein RBD (C-6His) V2(Active) is produced using advanced recombinant DNA technology, ensuring high purity and quality. This product is ideal for researchers and scientists who are studying the SARS-CoV-2 virus and its interactions with human cells. It can be used to investigate the mechanisms of viral entry and to develop potential treatments and vaccines.
This product is supplied in a lyophilized form, making it easy to store and transport. It is also available in various quantities to suit the needs of different research projects. The Recombinant SARS-CoV-2 S Protein RBD (C-6His) V2(Active) is a valuable tool for researchers and scientists who are working towards a better understanding of the SARS-CoV-2 virus and its impact on human health.
Share
